Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of SJQYD alleviate Sjögren’s Syndrome on protein expression of NOD/LTJ mice

ABSTRACT: We conducted experiments on SJQYD against Sjögren's Syndrome in NOD/LTJ mice.

ORGANISM(S): Mus Musculus

SUBMITTER: Luping Qin

PROVIDER: PXD051120 | iProX | Wed Mar 27 00:00:00 GMT 2024

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

Effect of SJQYD alleviate Sjögren’s Syndrome on gene expression of NOD/LTJ mice

Project description:We conducted experiments on SJQYD against Sjögren's Syndrome in NOD/LTJ mice. We used RNA sequencing to analyze the potential pathways of SJQYD.

2023-11-18 | GSE247662 | GEO

Effect of SJQYD alleviate Sjögren’s Syndrome on gene expression of NOD/LTJ mice

Project description:Effect of SJQYD alleviate Sjögren’s Syndrome on gene expression of NOD/LTJ mice

| PRJNA1040125 | ENA

Marfan syndrome in mice

Project description:Marfan syndrome in mice

| PRJNA431794 | ENA

Up-regulation of prolactin receptor in the proximal tubular cells in cardio-renal syndrome model mice

Project description:The precise physiological mechanisms of cardio-renal syndrome are yet to be elucidated. In order to investigate the molecular basis of cardio-renal syndrome, we established a mouse model for cardio-renal syndrome by the combination of abdominal aortic banding and uninephrectomy. Renal function of the cardio-renal syndrome mice was synergistically decreased compared with that of mice that underwent uninephrectomy alone. To investigate the molecules involved in the deterioration renal function in the AbNx mice, we conducted comprehensive gene expression analysis using DNA array by comparing the molecules expressed in the remained kidney of AbNx mice with those of Nx mice. We conducted abdominal aorta banding or sham operation at 0 week, then We conducted uninephrectomy or sham operation at 2 week. We removed these kidney 6week after the uninephrectomy. These RNA samples were purified from the homogenized kidneys.

2012-03-19 | E-GEOD-36591 | biostudies-arrayexpress

Inhibiting FKBP5 might alleviate obstetric antiphospholipid syndrome by regulating macrophage polarization.

Project description:The disturbance of immune balance at the maternal-fetal interface is a significant contributor to obstetric antiphospholipid syndrome (OAPS); however, the precise mechanisms underlying this disturbance remain unclear. This study investigates the immune regulatory role of FK506-binding protein 5 (FKBP5) to elucidate its molecular mechanisms in pathological pregnancies associated with OAPS. We conducted RNA sequencing (RNA-seq) analysis and immune cell typing on decidual tissue from OAPS patients and healthy controls. The results indicated that the FKBP5 gene and inflammation-related pathways were significantly expressed in the maternal-fetal interface of OAPS patients, characterized by an increase in M1 (iNOS+/CD86+) macrophages and a decrease in M2 (Arg-1+/CD206+) macrophages. In vitro experiments demonstrated that FKBP5 promotes M1-like polarization of macrophages via the JAK1/STAT1 pathway while inhibiting M2-like polarization through the PPARγ/STAT6 pathway. Using a macrophage-trophoblast cell co-culture model, we found that FKBP5-induced abnormal macrophage polarization at the maternal-fetal interface negatively impacted the migration, invasion, and proliferation of trophoblast cells. In a mouse model of OAPS, the knockout of FKBP5 regulated the abnormal polarization of macrophages between M1 and M2 phenotypes, facilitated epithelial-to-mesenchymal transition (EMT), and mitigated antiphospholipid antibodies (aPLs)-mediated placental pathological damage. Notably, SAFit2, a small molecule inhibitor of FKBP5, effectively improved adverse pregnancy outcomes in OAPS mice. The immune microenvironment imbalance at the maternal-fetal interface, driven by FKBP5-regulated macrophage polarization, constitutes a critical immunological basis for aPLs-mediated placental damage. Therefore, FKBP5 presents a potential therapeutic target for OAPS.

2025-04-07 | GSE283798 | GEO

Up-regulation of prolactin receptor in the proximal tubular cells in cardio-renal syndrome model mice

2012-03-19 | GSE36591 | GEO

Exon level gene expression profile of the prefrontal cortex region of Df(16)A+/- mice, a mouse model of 22q11.2 microdeletion syndrome

Project description:Df16(A)+/- mice line is a model of human 22q11 microdeletion syndrome. We conducted an unbiased evaluation of the transcriptional difference in the prefrontal cortex between mutant and wild type animals at exon level. These mice were generated by chromosomal engineering and carry a microdeltion of ~1.3Mb in the mouse locus syntenic to the human 22q11.1 The reasoning behind this expression profiling is that consistent alterations in transcriptional programs reflect either downstream (immediate or remote) effects of the deficiency or reactive (compensatory) changes, and can thus point to affected biological processes and molecular functions. Df(16)A+/- mice line is a model of human 22q11 microdeletion syndrome.

2013-10-21 | GSE45935 | GEO

Dynamical network biomarker analysis using multi-organ RNA sequencing in metabolic syndrome model mice

Project description:Dynamical network biomarker (DNB) theory has emerged as a powerful framework for detecting early warning signals of pre-disease states. Based on our previous work demonstrating its utility in adipose tissue of metabolic syndrome model mice, we conducted a comprehensive DNB analysis using RNA sequencing data across 13 organs and 14 to 16 time points in high-fat diet-fed mice. Our findings revealed organ-specific variation in the timing of early warning signals, suggesting heterogeneous inter-organ dynamics during the pre-disease state of metabolic syndrome. These results highlight the potential of DNB theory for elucidating systemic early-stage pathophysiology in complex metabolic disorders.

2025-08-23 | GSE305719 | GEO

Exon level gene expression profile of the prefrontal cortex region of Df(16)A+/- mice, a mouse model of 22q11.2 microdeletion syndrome

2013-10-21 | E-GEOD-45935 | biostudies-arrayexpress

Autoantibodies in sera from Sjogren's syndrome mice

Project description:Autoantibodies in sera from Sjogren's syndrome mice

| PRJNA685989 | ENA